Week 24: The Six-Month Milestone
Half a year of semaglutide. Twenty-four injections, every titration step behind you, two full months at the target dose. The six-month milestone is the standard clinical checkpoint and a natural moment to take stock of the full picture.
Week 24 marks six months on semaglutide. By STEP 1 trial data, the average user on the full titration schedule has lost roughly 10% of their starting body weight by this point — a meaningful number, though wide individual variation is the rule rather than the exception. Some users are well ahead of that average, some behind, and both are normal.
This is the canonical clinical checkpoint. Most prescribers will want a structured review around this time, and it is the point at which long-term decisions start to shape the rest of treatment. Dose continuation, eventual taper, body composition assessment, comorbidity management, and the longer planning horizon all tend to come into focus here.
Appetite Suppression
Steady and deep. The baseline at six months is generally what the rest of treatment looks like, barring dose changes.
Mean cumulative loss by week 24 in STEP trial cohorts was around 10% of starting weight, with wide individual variation.
The Week 24 Timeline
The Week 24 Timeline
Day 162 (Injection 24)
Half-Year Injection
Twenty-fourth injection. A symbolic milestone — the medication has been part of your weekly rhythm for half a year.
Days 164-166
Six-Month Review
The full picture: weight trend, side effect history, habit changes, energy and mood, body composition if available, lab work if requested. Bring it all to the conversation.
Day 168
Forward Plan
Confirm the next phase with your prescriber. Continue at 2.4mg, hold at a lower dose, plan an eventual taper, or anything else — the plan should be explicit, not implied.
Navigating Symptoms
At six months, the side effect picture is the side effect picture. Persistent issues that have not responded to lifestyle interventions are worth a focused discussion.
What to focus on this week is the trend, the habits, and the long horizon. The trend over six months should be a meaningfully downward weight line, even with flat weeks and plateaus along the way. The habits should be more or less automatic by now — the things you do without thinking, not the things you have to fight to remember. The long horizon is the question of what the next six months and beyond look like, which is worth defining rather than drifting into.
It is also worth pausing to acknowledge the work. Twenty-four injections, multiple titrations, side effects navigated, food choices made, routines built, and identity shifts processed. Six months is a real chunk of life, and the work you have put in is the foundation for whatever the journey looks like from here.
What Users Report
“Six months in. Down a meaningful amount, side effects under control, habits that feel real. My prescriber and I agreed to stay the course for the next six months and reassess.”
— Iris L.
“I'm a little behind the trial averages but the trend has been steadily down for six months. We talked about it and decided the response is real and worth continuing — number on the scale is not the only measure.”
— Pedro V.
Looking ahead
Beyond week 24, the journey shifts further into long-term maintenance work — the steady accumulation of small gains, the navigation of plateaus, and the eventual questions about taper, discontinuation, or extended treatment. Visit the resources hub for guides on the months ahead, or revisit earlier weeks to see how the picture has changed.